In vitro biological assessment of berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Abd El Wahab, Abeer E ^b   Ghareeb, Doaa A ^a,b   Sarhan, Eman E M ^b   Abu Serie, Marwa M ^b   El Demellawy, Maha A ^b  

^a Alexandria University Faculty Of Science   (Egypt)

^b GENETIC ENGINEERING AND BIOTECHNOLOGY RESEARCH INSTITUTE   (Egypt)

Author keywords

Acetylcholinesterase; Bioscreening; Breast cancer; CACO 2; DPPH; Hepatoma; PBMC; glucosidase

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETYLCHOLINESTERASE; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BERBERINE; BERBERINE CHLORIDE; BERBERIS VULGARIS EXTRACT; CHOLINESTERASE INHIBITOR; GLUTATHIONE PEROXIDASE; NEUTRAL RED; NITRIC OXIDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIDIABETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; BERBERIS; BERBERIS VULGARIS; BIOLOGICAL ACTIVITY; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MOUSE; NEUTRAL RED UPTAKE ASSAY; NONHUMAN; OXIDATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PLANT ROOT; SPECTROPHOTOMETRY;

ACETYLCHOLINESTERASE; ALPHA-GLUCOSIDASES; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BERBERINE; BERBERIS; CELL LINE, TUMOR; CELL SURVIVAL; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; ETHANOL; GLUTATHIONE PEROXIDASE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT ROOTS; SUPEROXIDE DISMUTASE; THIOBARBITURATES;

EID: 84883462685     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-218     Document Type: Article

References (71)

1. El-Sayed M, Ghareeb DA, Sarhan EM, Khalil AA. Therapeutic Bio-screening of the bioactive extracted ingredients of Berberis vulgaris, berberine. FPSB 2011, 5:63-68.
2. Flora of New South Wales, Volume 1 2000, Kensington: NSW University Press, Harden GJ.
3. Grieve M. 1931. A Modern Herbal 1994, London: Tiger Books International.
4. Arayne MS, Sultana N, Bahadur SS. The berberis story: Berberis vulgaris in therapeutics. Pakistan J Pharmacol Sci 2007, 20(1):83-92.
5. Zargari A. Medicinal Plants 1983, Tehran: Tehran University Press, 1:68.
6. Chevallier A. The Encyclopedia of Medicinal Plants 2001, St Leonards: Dorling Kindersley.
7. Souri EAG, Dehmobed-Sharifabadi A, Nazifi A, Farsam H. Antioxidant activity of sixty plants from Iran. Iranian J Pharm Res 2004, 3:55-59.
8. Timothy CBN, Gregory S, Kelly ND. Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 1997, 2:94-103.
9. Kunwar RM, Nepal BK, Kshhetri HB, Rai SK, Bussmann RW. Ethnomedicine in Himalaya: a case study from Dolpa, Humla, Jumla and Mustang districts of Nepal. J Ethnobiol Ethnomed 2006, 2:27. 10.1186/1746-4269-2-27, 1513199, 16749924.
10. Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res 2005, 19(3):222-225. 10.1002/ptr.1661, 15934023.
11. Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 1996, 18(10):553-561. 10.1016/S0192-0561(96)00047-1, 9080249.
12. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, Berberine. Phytotherapy Research 2008. Published online at Wiley InterScience. Adv Physiol Educ doi:10.1002/ptr.2399 (http://www.interscience.wiley.com).
13. Mills S, Bone K. Principals and Practice of Phytotherapy 2000, Edinburgh: Churchill Livingstone.
14. Bone K. A Clinical Guide to Blending Liquid Herbs: herbal formulations for the individual patient 2003, St Louis, Missouri: Churchill Livingstone.
15. Li SY, TheBS LL, Seow WK, Thong YH. Anti-inflammatory and immuno-suppressive properties of the bis-benzylquinolones: in-vitro comparisons of tetrandrine and berbamine. Int J Immunopharmacol 1989, 11:395-441. 10.1016/0192-0561(89)90086-6, 2777433.
16. Khosrokhavar R, Ahmadiani ASF. Antihistaminic and Anticholinergic Activity of Methanolic Extract of Barberry Fruit (Berberis vulgaris) in the Guinea- Pig Ileum. J Med Plants 2010, 9:99-105.
17. Akhter MH. SMaBN: Possible mechanism of antidiarrheal effect of berberine. Indian J Med Res 1979, 70:233-241.
18. Rabbani GHBT, Knight J, Sanyal SC, Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholera. J Infect Dis 1987, 155:979-984. 10.1093/infdis/155.5.979, 3549923.
19. Amin AH, Subbaiah TV, Abbasi KM. Berberine sulfate: antimidrobial activity, bioassay, and mode of action. Can J Microbiol 1969, 15:1067-1076. 10.1139/m69-190, 4906191.
20. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics 1996, 66-67. New York: Wiley Publishers.
21. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008, 22:999-1012. 10.1002/ptr.2399, 18618524.
22. Sabir M. Study of some pharmacological actions of berberine. Indian J Physiol Pharmacol 1971, 15:111-132.
23. Kuo C, Chi C, Liu T. The anti-inflammatory potential of berberine in-vitro and in-vivo. Cancer Lett 2004, 203:127-137. 10.1016/j.canlet.2003.09.002, 14732220.
24. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther 2000, 294(3):822-829.
25. KF L. Berberine. Adverse Effects of Herbal Drugs 1994, 97-98. Berlin: Springer Verlag, Pagm KK, Hansel R, Chandler RF.
26. Shamsa F, Ahmadiani A, Khosrokhavar R. Antihistaminic and anticholinergic activity of berberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Ethnopharmacol 1999, 64:161-166. 10.1016/S0378-8741(98)00122-6, 10197751.
27. Tomosaka H, Salim AA, Keller WJ, Chai H, Kinghorn AD. Antioxidant and cytoprotective compounds from Berberis vulgaris (barberry). Phytother Res 2008, 22:979-981. 10.1002/ptr.2443, 18389483.
28. Cohen-Boulakia F. In-vivo sequential study of skeletal muscle capillary permeability in diabetic rats. Metabolism 2000, 49:880-885. 10.1053/meta.2000.6754, 10909999.
29. Meiers S. The anthocyanidins cyaniding and delphinidin are potent inhibitors of the epidermal growth factor receptor. J Agric Food Chem 2000, 49:958-962.
30. http://www.mohp.gov.eg/default.aspx#, Egyptian Ministry of Health and Population, Arab Republic of Egypt, 9/5/2013, 11:30 PM.
31. http://www.dragonherbarium.com/bulk-herbs-spices/bulk-herbs-b/barberry-root-bark-cs-wc-berberis-vulgaris.
32. Qadir S, Han J, Ji H, Chung H, Ahn J, Lee H. Effect of different extraction protocols on anticancer and antioxidant activities of berberis koreana bark extracts. J Biosci Bioeng 2009, 107:331-339. 10.1016/j.jbiosc.2008.11.021, 19269602.
33. Ellman G, Andres V, Featherstone RA. New and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95. 10.1016/0006-2952(61)90145-9, 13726518.
34. Han YN, Srinivasan VR. Purification and characterization of beta-glucosidase of Alcaligenesfaecalis. J Bacteriol 1969, 100:1355-1363. 250337, 5361217.
35. Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1965, 99(3):667-676.
36. Choi DW, King YC, Leroy P, Siest G, Wellman M. Differential role of CYP2E1 binders and isoniazid on CYP2E1 protein modification in NADPHdependent microsomal oxidative reactions: FR scavenging ability of isoniazid. Free Radic Res 2002, 36:893-904. 10.1080/1071576021000005339, 12420748.
37. Green LC, Glogowski J. Analysis of nitrate, nitrite and nitrate in biological fluids. Anal Biochem 1982, 126:131-138. 10.1016/0003-2697(82)90118-X, 7181105.
38. Marklund S, Marklund G. Involvement of the superoxide anion radical in the auto oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 74:469-474.
39. Paglia E, Valentine N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clinic Med 1967, 70:158-169.
40. Repetto G, Zurita J. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008, 3:1125-1131. 10.1038/nprot.2008.75, 18600217.
41. Wongbutdee J. physiological effects of berberine. Thai Pharm Health Sci J 2008, 4:78-83.
42. Ghareeb D, Newarry A, El-Rashidy F, Hussein H, Ali A. Efficacy of natural extracts of Ginkgo biloba and barberry and a synthetic derivative of genistein (ipriflavone), as acetylcholinesterase inhibitors, comparative study with Aricept® effect. J Biochem Biotechnol 2010, 1:15-20.
43. Muñoz-Torrero D. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. Curr Med Chem 2008, 15:2433-2455. 10.2174/092986708785909067, 18855672.
44. Yibchok-anun S, Jittaprasatsin W, Somtir D, Bunlunara W, Adisakwattana S. Insulin secreting and a-glucosidase inhibitory activity of Coscinium fenestratum and postprandial hyperglycemia in normal and diabetic rats. J Med Plants Res 2009, 3(9):646-651.
45. Bijvoet A, Pieper F, Vliet M, Boer H, Ploeg A, Verbeet M, Reuser A. Recombinant human acid α-glucosidase: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice. Hum Mol Genet 1998, 7:1815-1824. 10.1093/hmg/7.11.1815, 9736785.
46. Frei B. Natural antioxidants in human health and disease 1994, San Diego: Academic Press.
47. Jagetia G, Baliga M, Babu K. The Evaluation of Nitric Oxide Scavenging Activity of Certain Herbal Formulations in vitro: A Preliminary Study. Phytother Res 2004, 18:561-565. 10.1002/ptr.1494, 15305317.
48. Tan W, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y, Guo J, Chen X, Wang Y. Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med 2011, 6:27-43. 10.1186/1749-8546-6-27, 3149025, 21777476.
49. Newman DJ, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003, 66:1022-1037. 10.1021/np030096l, 12880330.
50. Ong ES, Woo SO, Yong YL. Pressurized liquid extraction of berberine and aristolochic acids in medicinal plants. J Chromatogr A 2000, 904:57-64. 10.1016/S0021-9673(00)00914-6, 11209901.
51. Yoo KY, Hwang IK, Kim JD, Kang IJ, Park J, Yi J, Kim JK, Bae YS, Won MH. Antiinflammatory effect of the ethanol extract of Berberis koreana in a gerbil model of cerebral ischemia/reperfusion. Phytother Res 2008, 22(11):1527-32. 10.1002/ptr.2527, 18688884.
52. Yoo KY, Hwang IK, Lim BO, Kang TC, Kim DW, Kim SM, Lee HY, Kim JD, Won MH. Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biol Pharm Bull 2006, 29(4):623-628. 10.1248/bpb.29.623, 16595891.
53. Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, Oh J, Kang SM, Chung JH, Jang Y. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol Cells 2005, 20(3):429-434.
54. Musumeci R, Speciale A, Costanzo R, Annino A, Ragusa S, Rapisarda A, Pappalardo MS, Iauk L. Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. Int J Antimicrob Agents 2003, 22(1):48-53. 10.1016/S0924-8579(03)00085-2, 12842327.
55. Chung JG, Chen GW, Hung CF, Lee JH, Ho CC, Ho HC, Chang HL, Lin WC, Lin JG. Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells. Am J Chin Med 2000, 28(2):227-238. 10.1142/S0192415X00000271, 10999441.
56. Ivanovska N, Philipov S, Hristova M. Influence of berberine on T-cell mediated immunity. Immunopharmacol Immunotoxicol 1999, 21(4):771-86. 10.3109/08923979909007141, 10584211.
57. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 1999, 66(2):227-33. 10.1016/S0378-8741(98)00162-7, 10433483.
58. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 2011, 10:39. 10.1186/1476-4598-10-39, 3098825, 21496227.
59. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010, 17(6):436-740. 10.1016/j.phymed.2009.08.012, 19800775.
60. Wang GY, Lv QH, Dong Q, Xu RZ, Dong QH. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J Asian Nat Prod Res 2009, 11(3):219-28. 10.1080/10286020802675076, 19408145.
61. Ho YT, Yang JS, Lu CC, Chiang JH, Li TC, Lin JJ, Lai KC, Liao CL, Lin JG, Chung JG. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model. Phytomedicine 2009, 16(9):887-890. 10.1016/j.phymed.2009.02.015, 19303753.
62. Hsieh YS, Kuo WH, Lin TW, Chang HR, Lin TH, Chen PN, Chu SC. Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells. J Agric Food Chem 2007, 55(25):10437-10445. 10.1021/jf071868c, 18001034.
63. Lin SS, Chung JG, Lin JP, Chuang JY, Chang WC, Wu JY, Tyan YS. Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells. Phytomedicine 2005, 12(5):351-358. 10.1016/j.phymed.2003.11.008, 15957369.
64. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med 1999, 65(4):381-387. 10.1055/s-2006-960795, 10364850.
65. Jenny M, Wondrak A, Zvetkova E, Tram N, Phiz P5, Schennach H, Culig Z, Ueberall F, Fuchs D. Crinum Latifolium Leave Extracts Suppress Immune Activation Cascades in Peripheral Blood Mononuclear Cells and Proliferation of Prostate Tumor Cells. Sci Pharm 2011, 79:323-335. 10.3797/scipharm.1011-13, 3134856, 21773069.
66. Fotakis G, Timbrell A. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160(2):171-177. 10.1016/j.toxlet.2005.07.001, 16111842.
67. Kim T, Kang B, Cho D, Kim S. Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology 2003, 109(3):407-414. 10.1046/j.1365-2567.2003.01673.x, 1782983, 12807487.
68. Kenny T, Keen C, Schmitz H, Gershwin M. Immune Effects of Cocoa Procyanidin Oligomers on Peripheral Blood Mononuclear Cells. Exp Biol Med 2007, 232:293-300.
69. Kashyap R, Husain A, Morey S, Panchbhai M, Deshpande P, Purohit H, Taori G, Daginawala H. Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model. J Immune Based Ther Vaccin 2010, 8:3.
70. http://plants.usda.gov/core/profile?symbol=bevu.
71. http://clarysageherbarium.com/herbs-etc./bulk-herbs/b.